Table 2: Results of laparoscopic operation and secondary look laparotomy (cytoreductive surgery + HIPEC).

Patient
no.
Procedures Operative
time (min)
PCI at LHIPECHospital stay after ope. (days)Postoperative
complications
Postoperative
serum CEA
Changes of ascites on CTPeriod from LHIPEC to SLL (days)PCI at SLLFollow-up period (months)

1LAp + LHIPEC1242516(−)Normal 165535
2LAp + LHIPEC2611413(−)Normal 55433
3LAp + LHIPEC1531214RDFNormal 2072326
4LAp + LHIPEC160124(−)Decreased Disappeared42829
5LAp + LHIPEC1513015(−)Decreased 1152723
6LAp + LHIPEC1892513(−)Decreased 841123
7LAp + LHIPEC201119RDFNormal 94718
8LAp14806(−)(−)(−)(−)(−)(−)
9LAp + LHIPEC2011211(−)Normal Disappeared4077
10LAp + LHIPEC189218(−)Decreased (−)(−)(−)
11LAp + LHIPEC172209(−)Elevated 50247

LAp: laparoscopic appendectomy.
LHIPEC: laparoscopic hyperthermic intraperitoneal chemotherapy.
PCI: peritoneal carcinomatosis index.
SLL: second look laparotomy.
RDF: renal dysfunction improved within 1 week.
No. 4: port site recurrence was revealed 10 months after LP1PEC.
No. 8: localized PMP (mucocele).